Inspire Historical Income Statement

INSP Stock

USD 164.92 2.17 1.33%

Historical analysis of Inspire Medical income statement accounts such as Interest Expense of 20.9 K or Selling General Administrative of 556.1 M can show how well Inspire Medical Systems performed in making a profits. Evaluating Inspire Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Inspire Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Inspire Medical Systems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Inspire Medical Systems is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Inspire Income Statement Analysis

Inspire Medical Systems Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Inspire Medical shareholders. The income statement also shows Inspire investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Inspire Medical Income Statement Chart

At this time, Inspire Medical's Operating Income is relatively stable compared to the past year. As of 03/21/2025, Net Income From Continuing Ops is likely to grow to about 56.2 M, while Interest Expense is likely to drop slightly above 20.9 K.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Income Before Tax

Total Revenue

Total revenue comprises all receipts Inspire Medical Systems generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Inspire Medical Systems minus its cost of goods sold. It is profit before Inspire Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Inspire Medical income statement and is an important metric when analyzing Inspire Medical Systems profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Inspire Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Inspire Medical Systems current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	2.9M	2.8M	6.6M	6.9M
Interest Income	5.1M	18.1M	23.2M	24.4M

Depreciation And Amortization Interest Income

Inspire Medical income statement Correlations

	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other
Interest Income		0.87	-0.82	0.96	0.93	0.95	0.95	0.94	0.66	0.76	0.73	0.94	0.75	0.95	0.93	0.82	0.99	0.81	0.77	1.0	0.95	0.87
Depreciation And Amortization	0.87		-0.6	0.91	0.87	0.91	0.91	0.9	0.53	0.64	0.63	0.86	0.66	0.9	0.9	0.68	0.83	0.66	0.59	0.88	0.92	0.81
Interest Expense	-0.82	-0.6		-0.74	-0.77	-0.75	-0.75	-0.73	-0.57	-0.64	-0.6	-0.77	-0.61	-0.75	-0.73	-0.7	-0.85	-0.69	-0.64	-0.83	-0.74	-0.7
Selling General Administrative	0.96	0.91	-0.74		0.99	1.0	1.0	1.0	0.52	0.64	0.61	0.99	0.63	1.0	0.99	0.69	0.94	0.68	0.65	0.96	0.95	0.82
Selling And Marketing Expenses	0.93	0.87	-0.77	0.99		0.99	0.99	0.99	0.5	0.62	0.59	0.99	0.61	0.99	0.99	0.68	0.93	0.66	0.63	0.94	0.93	0.82
Total Revenue	0.95	0.91	-0.75	1.0	0.99		1.0	1.0	0.53	0.64	0.62	0.99	0.64	1.0	1.0	0.7	0.94	0.68	0.66	0.96	0.95	0.83
Gross Profit	0.95	0.91	-0.75	1.0	0.99	1.0		1.0	0.53	0.64	0.62	0.99	0.64	1.0	1.0	0.7	0.94	0.68	0.66	0.96	0.95	0.83
Other Operating Expenses	0.94	0.9	-0.73	1.0	0.99	1.0	1.0		0.46	0.58	0.56	0.99	0.58	1.0	1.0	0.64	0.93	0.63	0.6	0.94	0.93	0.82
Operating Income	0.66	0.53	-0.57	0.52	0.5	0.53	0.53	0.46		0.99	0.99	0.43	0.98	0.53	0.45	0.97	0.63	0.98	0.96	0.65	0.73	0.5
Net Income From Continuing Ops	0.76	0.64	-0.64	0.64	0.62	0.64	0.64	0.58	0.99		1.0	0.55	1.0	0.64	0.57	0.99	0.73	1.0	0.98	0.75	0.82	0.6
Ebit	0.73	0.63	-0.6	0.61	0.59	0.62	0.62	0.56	0.99	1.0		0.52	1.0	0.62	0.55	0.99	0.7	0.99	0.98	0.72	0.81	0.57
Research Development	0.94	0.86	-0.77	0.99	0.99	0.99	0.99	0.99	0.43	0.55	0.52		0.55	0.99	0.99	0.62	0.94	0.61	0.58	0.95	0.9	0.82
Ebitda	0.75	0.66	-0.61	0.63	0.61	0.64	0.64	0.58	0.98	1.0	1.0	0.55		0.64	0.57	0.98	0.71	0.98	0.97	0.73	0.83	0.59
Cost Of Revenue	0.95	0.9	-0.75	1.0	0.99	1.0	1.0	1.0	0.53	0.64	0.62	0.99	0.64		1.0	0.7	0.94	0.68	0.66	0.96	0.95	0.84
Total Operating Expenses	0.93	0.9	-0.73	0.99	0.99	1.0	1.0	1.0	0.45	0.57	0.55	0.99	0.57	1.0		0.63	0.92	0.62	0.59	0.94	0.93	0.82
Income Before Tax	0.82	0.68	-0.7	0.69	0.68	0.7	0.7	0.64	0.97	0.99	0.99	0.62	0.98	0.7	0.63		0.8	1.0	0.98	0.81	0.85	0.65
Total Other Income Expense Net	0.99	0.83	-0.85	0.94	0.93	0.94	0.94	0.93	0.63	0.73	0.7	0.94	0.71	0.94	0.92	0.8		0.79	0.75	1.0	0.92	0.86
Net Income	0.81	0.66	-0.69	0.68	0.66	0.68	0.68	0.63	0.98	1.0	0.99	0.61	0.98	0.68	0.62	1.0	0.79		0.98	0.8	0.84	0.64
Income Tax Expense	0.77	0.59	-0.64	0.65	0.63	0.66	0.66	0.6	0.96	0.98	0.98	0.58	0.97	0.66	0.59	0.98	0.75	0.98		0.76	0.82	0.61
Net Interest Income	1.0	0.88	-0.83	0.96	0.94	0.96	0.96	0.94	0.65	0.75	0.72	0.95	0.73	0.96	0.94	0.81	1.0	0.8	0.76		0.95	0.87
Reconciled Depreciation	0.95	0.92	-0.74	0.95	0.93	0.95	0.95	0.93	0.73	0.82	0.81	0.9	0.83	0.95	0.93	0.85	0.92	0.84	0.82	0.95		0.79
Non Operating Income Net Other	0.87	0.81	-0.7	0.82	0.82	0.83	0.83	0.82	0.5	0.6	0.57	0.82	0.59	0.84	0.82	0.65	0.86	0.64	0.61	0.87	0.79

Click cells to compare fundamentals

Inspire Medical Account Relationship Matchups

Inspire Medical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Income	1.1M	125K	5.1M	18.1M	23.2M	24.4M
Depreciation And Amortization	1.8M	2.0M	2.9M	2.8M	6.6M	6.9M
Interest Expense	2.1M	2.1M	1.7M	0.0	22K	20.9K
Selling General Administrative	101.5M	154.8M	246.4M	422.7M	529.6M	556.1M
Selling And Marketing Expenses	26.4M	47.8M	74.3M	100.3M	115.3M	121.1M
Total Revenue	115.4M	233.4M	407.9M	624.8M	802.8M	842.9M
Gross Profit	97.8M	200.1M	341.7M	528.2M	679.8M	713.8M
Other Operating Expenses	171.6M	273.2M	455.4M	665.1M	766.7M	805.1M
Operating Income	(56.2M)	(39.9M)	(47.6M)	(40.3M)	36.1M	37.9M
Net Income From Continuing Ops	(57.2M)	(42.0M)	(44.9M)	(32.8M)	53.5M	56.2M
Ebit	(55.0M)	(40.6M)	(42.6M)	(40.3M)	58.5M	61.4M
Research Development	26.1M	37.4M	68.6M	116.5M	114.1M	119.8M
Ebitda	(53.2M)	(38.6M)	(39.7M)	(40.3M)	65.0M	68.3M
Cost Of Revenue	17.6M	33.3M	66.1M	96.6M	123.0M	129.1M
Total Operating Expenses	154.0M	240.0M	389.3M	568.5M	643.7M	675.9M
Income Before Tax	(57.1M)	(42.0M)	(44.3M)	(19.9M)	58.5M	61.4M
Total Other Income Expense Net	(880K)	(2.1M)	3.3M	20.4M	22.4M	23.5M
Net Income Applicable To Common Shares	(33.2M)	(57.2M)	(42.0M)	(44.9M)	(40.4M)	(42.4M)
Net Income	(57.2M)	(42.0M)	(44.9M)	(21.2M)	53.5M	56.2M
Income Tax Expense	115K	72K	613K	1.2M	4.9M	5.2M
Tax Provision	115K	72K	613K	895K	4.9M	5.2M
Net Interest Income	(1.0M)	(2.0M)	3.4M	18.1M	23.2M	24.4M
Reconciled Depreciation	840K	1.2M	1.9M	2.6M	6.6M	6.9M
Non Operating Income Net Other	3.8M	1.2M	(76K)	4.9M	5.6M	5.9M

Pair Trading with Inspire Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inspire Stock

0.62

GKOS

Glaukos Corp

Pair Corr

Moving against Inspire Stock

0.49	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.36	FNA	Paragon 28	Pair Corr
0.36	LUNG	Pulmonx Corp	Pair Corr
0.34	INMD	InMode	Pair Corr
0.31	KIDS	Orthopediatrics Corp	Pair Corr

The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.

The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inspire Historical Income Statement

About Inspire Income Statement Analysis

Inspire Medical Income Statement Chart

Total Revenue

Gross Profit

Income Before Tax

Inspire Medical income statement Correlations

Inspire Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Inspire Medical income statement Accounts

Pair Trading with Inspire Medical

Moving together with Inspire Stock

Moving against Inspire Stock

Additional Tools for Inspire Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Interest Income	+ 1.0	Interest Income
Total Revenue	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative
Cost Of Revenue	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Total Revenue

Total Other Income Expense Net	- 0.85	Interest Expense
Net Interest Income	- 0.83	Interest Expense
Interest Expense	- 0.82	Interest Income
Research Development	- 0.77	Interest Expense
Selling And Marketing Expenses	- 0.77	Interest Expense
Cost Of Revenue	- 0.75	Interest Expense